Page 1

ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email!

MarketVIEW: Universal influenza vaccines Published on March 2011

Report Summary Influenza, an acute febrile disease of the respiratory system, is caused by an enveloped RNA virus where types A and B cause disease in humans. The disease, which occurs in yearly epidemics (seasonal), and unpredictable pandemics, exerts enormous global burden in terms of mortality, morbidity and economic cost. Yearly vaccination is the mainstay of protection against the constantly changing influenza virus. Currently, a number of influenza vaccines are available and given according to national recommendations to an increasing percentage of the population with a focus on protecting the most vulnerable such as the very young, very old and immunocompromised. Vaccines are mainly of the trivalent inactivated (TIV) format produced by older technology in egg-based production systems. While effective, they have limitations being addressed by manufacturers with cell-based production systems, adjuvantation or alternative delivery systems. However, in the longer term, a more desirable goal is to produce a "universal vaccine" that can protect against all types of influenza viruses (season and pandemic) with lasting protection. This MarketVIEW product is a comprehensive value ($ 000s) and volume (doses) forecast indicating the commercial potential of new universal influenza vaccines across the major Western markets to 2035 in all current population segments. The model explores the impact of alternative uptake scenarios (LO/HI) and the value of universal antigens as part of seperate new products or adjuncts to existing vaccines. In an accompanying Executive presentation, discussion is included with regard to current competitor approaches, target product profile (TPP) analysis and other major commercial assumptions e.g. pricing, boosting, strain coverage and market dynamics. Early indications of expected revenues per competitor, both POS and NOS-POS adjusted are also indicated. THIS PRODUCT IS A SUMMARY PRESENTATION + 2 MODELS

MarketVIEW: Universal influenza vaccines (From Issuu)

Page 1/3


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ

Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93

If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information Please verify that the product information is correct and select the format(s) you require. MarketVIEW: Universal influenza vaccines

Product Formats Please select the product formats and the quantity you require. Site License--USD 9 995.00

Quantity: _____

Global Site--USD 11 995.00

Quantity: _____

Contact Information Please enter all the information below in BLOCK CAPITALS

Title:

Mr

Mrs

Dr

Miss

Ms

Prof

First Name:

_____________________________ Last Name: __________________________________

Email Address:

__________________________________________________________________________

Job Title:

__________________________________________________________________________

Organization:

__________________________________________________________________________

Address:

__________________________________________________________________________

City:

__________________________________________________________________________

Postal / Zip Code:

__________________________________________________________________________

Country:

__________________________________________________________________________

Phone Number:

__________________________________________________________________________

Fax Number:

__________________________________________________________________________

MarketVIEW: Universal influenza vaccines (From Issuu)

Page 2/3


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card

Card Number: ______________________________________________

Expiry Date

__________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer

Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check

UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms

Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56

ƒ ƒ

MarketVIEW: Universal influenza vaccines (From Issuu)

Asia, Oceania and America : + 1 (805) 617 17 93

Page 3/3

MarketVIEW: Universal influenza vaccines  

Influenza, an acute febrile disease of the respiratory system, is caused by an enveloped RNA virus where types A and B cause disease in huma...

Read more
Read more
Similar to
Popular now
Just for you